Business Context and Reporting Period
Company: Future Vision II Acquisition Corp. (FVN)
Reporting Period: Annual Report (Form 10-K) for the period from inception (January 30, 2024) through December 31, 2024.
Business Overview: The Company is a Cayman Islands exempted company formed as a "blank check" SPAC to effect a merger, share exchange, or asset acquisition with one or more target businesses, primarily in Asia. As of December 31, 2024, the Company had not commenced operations and generated no operating revenues. Its activities were limited to organizational efforts and the Initial Public Offering (IPO).
Proposed Business Combination: On November 28, 2024, the Company entered into a Merger Agreement to acquire Viwo Technology Inc. ("Viwo"), a technology company specializing in business technology services. The transaction values Viwo at $100,000,000. Upon closing, the Company will change its name to "Viwo Inc."
Key Financial Metrics
| Metric | Amount (USD) |
|---|---|
| Net Income (Inception to Dec 31, 2024) | $640,343 |
| Total Assets (Dec 31, 2024) | $59,943,182 |
| Cash and Cash Equivalents (Operating) | $1,332,505 |
| Marketable Securities in Trust Account | $58,605,697 |
| Total Liabilities | $111,333 |
| Shareholders' Equity | $7,694,207 |
| Ordinary Shares Subject to Redemption | $52,137,642 |
| Operating Expenses | $190,611 |
| Interest Income (Trust Account) | $818,197 |
Material Changes and IPO Details
The Company consummated its IPO on September 13, 2024, selling 5,750,000 Units (including the full exercise of the over-allotment option) at $10.00 per Unit, generating gross proceeds of $57,500,000. Simultaneously, the Sponsor purchased 299,000 Private Placement Units for $2,990,000.
Trust Account: Approximately $57,500,000 was deposited into the Trust Account. As of December 31, 2024, the Trust Account balance grew to $58,605,697 due to interest income earned on U.S. government securities.
Capital Structure: As of December 31, 2024, there were 7,544,000 ordinary shares issued and outstanding. This includes 5,750,000 public shares subject to redemption and 1,794,000 permanent equity shares (Founder Shares, Private Placement Shares, and Representative Shares).
Guidance, Outlook, and Risks
Outlook and Timeline: The Company has 18 months from the IPO closing (until March 13, 2026) to consummate a business combination. This period may be extended up to six times by one month each (totaling 24 months) if the Sponsor deposits $191,475 per month into the Trust Account. If no combination is completed by the deadline, the Company will liquidate and redeem public shares.
Management Commentary: Management has identified Viwo as the target for the initial business combination. The transaction is subject to customary closing conditions, including shareholder approval and regulatory filings (including CSRC filings in China).
Going Concern: The Company has raised substantial doubt about its ability to continue as a going concern. This is due to the mandatory liquidation requirement if a business combination is not completed within the specified timeframe. Management's plan to address this is to consummate the proposed business combination with Viwo.
Key Risks:
- Regulatory Risks (China): Significant risks related to acquiring a target with operations in China, including cybersecurity reviews, data privacy laws, and potential government intervention.
- Redemption Risk: If a significant number of public shareholders redeem their shares, the Company may fail to meet the $5,000,001 net tangible asset requirement for closing the Viwo transaction.
- Lock-Up Provisions: Viwo shareholders are subject to a performance-based lock-up agreement (2 to 3 years) contingent on revenue growth targets.
- HFCAA Compliance: Risks associated with the Holding Foreign Companies Accountable Act regarding auditor inspections for companies with operations in China.
Investor Verification Checklist
- Viwo Financials: Verify the audited financial statements and revenue growth projections of Viwo Technology Inc. to assess the feasibility of the lock-up performance targets.
- Regulatory Approvals: Monitor the status of the China Securities Regulatory Commission (CSRC) filings and cybersecurity reviews required for the transaction.
- Redemption Levels: Track shareholder redemption rates prior to the shareholder vote to ensure the Company maintains the required $5,000,001 net tangible assets.
- Extension Funding: Confirm the Sponsor's ability and willingness to fund monthly extensions ($191,475/month) if the deal timeline slips beyond 18 months.
- Deferred Underwriting: Note the $575,000 deferred underwriting commission payable only upon successful consummation of the business combination.